return to corporate website
Menu
Return to
www.noxopharm.com
Home
About Us
About Noxopharm
Management Team
Board of Directors
Scientific Advisors
Corporate Governance
Company Constitution
Sustainability
Noxopharm History
Research and Clinical Programs
Research and Clinical Programs
About Pharmorage
Investor Centre
Share Price
ASX Announcements
Why Invest in Noxopharm
Presentations & Interviews
Annual Reports
Financial Reports
Analyst Reports
Investor Fact Sheet
Investor FAQs
Upcoming Events
Privacy Policy
Share Registry Information
Contact Us
Contact Us
Partnering
Working at Noxopharm
Newsletter Email Alerts
ASX Announcements Email Alerts
Investor Centre
Home
>
Investor Centre
>
Analyst Reports
Share Price
ASX Announcements
Why Invest in Noxopharm
Presentations & Interviews
Annual Reports
Financial Reports
Analyst Reports
Investor Fact Sheet
Investor FAQs
Upcoming Events
Privacy Policy
Share Registry Information
Analyst Reports
5-Aug-2020
Pitt Street Research Report 2
23-Apr-2020
Pitt Street Research Initiation Report
5-Sep-2018
EverBlu Capital Research Report: A Closer Look at Nyrada - a Noxopharm subsidiary company.
12-Jul-2018
Noxopharm Research Report prepared by EverBlu Capital Research July 2018
27-Jul-2017
NOX Research Report prepared by APP Securities
25-May-2017
Independent Investment Research Report May 2017
16-Nov-2016
Independent Investment Research Report November 2016
19-Sep-2016
APP Securities Company Research Report September 2016
